Area of research
Oncology · Molecular Biology
Research interest
Research interests include Protein Degradation and Inhibitors, CAR-T cell therapy research, Cancer Immunotherapy and Biomarkers, and HER2/EGFR in Cancer Research.
Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study
Phase I/IIa Trial of BMS-986148, an Anti-mesothelin Antibody-drug Conjugate, Alone or in Combination with Nivolumab in Patients with Advanced Solid Tumors
EUR Research Repository (Erasmus University Rotterdam) 2022cited by 50position: middle